Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Testing effectiveness (Phase 2)Study completedNCT02743897
What this trial is testing

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 62
Not applicableStudy completedNCT03612973
What this trial is testing

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Who this might be right for
Chronic Hepatitis c
Assiut University 80
Not applicableUnknownNCT03775798
What this trial is testing

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Who this might be right for
Hepatitis CCirrhosisAntiviral Drug Adverse Reaction
Austral University, Argentina 2,200
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Post-approval studies (Phase 4)Study completedNCT02533934
What this trial is testing

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Who this might be right for
HIVHepatitis CCirrhosis
University of California, San Francisco 68
Post-approval studies (Phase 4)UnknownNCT04169464
What this trial is testing

The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy

Who this might be right for
Egyptian Patients, HCV Treatment, Kidney Function
MTI University 200
Not applicableStudy completedNCT01945008
What this trial is testing

Observational Study in HCV Chronic Infection

Who this might be right for
Hepatitis C, Chronic
Istituto Superiore di Sanità 7,600
Post-approval studies (Phase 4)UnknownNCT04267458
What this trial is testing

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

Who this might be right for
Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment
Cairo University 300
Not applicableStudy completedNCT03342261
What this trial is testing

Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Who this might be right for
Hepatitis C, ChronicMixed Cryoglobulinemia
Hospices Civils de Lyon 47
Not applicableUnknownNCT04220151
What this trial is testing

Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C

Who this might be right for
Hepatocellular Carcinoma
Assiut University 100
Not applicableUnknownNCT05372874
What this trial is testing

Treatment of Hepatitis c by Using Direct-acting Antiviral

Who this might be right for
Hepatitis C
Tanta University 50
Testing effectiveness (Phase 2)Study completedNCT01356160
What this trial is testing

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 351
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Testing effectiveness (Phase 2)Study completedNCT02536313
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 49
Post-approval studies (Phase 4)WithdrawnNCT03093740
What this trial is testing

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Who this might be right for
Renal Failure ChronicHepatitis C
Massachusetts General Hospital
Post-approval studies (Phase 4)UnknownNCT03888729
What this trial is testing

Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)

Who this might be right for
Hepatitis C, Chronic
Partners in Health 100
Not applicableUnknownNCT04952207
What this trial is testing

Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Qing XIe 300
Post-approval studies (Phase 4)UnknownNCT03296930
What this trial is testing

Effect Of DAAs For Treatment Of HCV On Normal Kidney

Who this might be right for
Antiviral Drug Adverse Reaction
Assiut University 100
Next Page